Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about lymphoma
Recent news which mentions lymphoma
Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
May 01, 2023
Tickers
BMY
IMTX
Tags
News
Large Cap
Health Care
From
Benzinga
Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus' Story
December 08, 2022
Tags
Gilead
CAR T/cell Therapy
Lymphoma
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey
April 20, 2022
Tags
CAR T/cell Therapy
Lymphoma
NYSE:GILD
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Discover Cord Blood’s Life-Saving Benefits at the 7th Annual Arizona Cord Blood Conference – United by Our Strengths
March 07, 2022
Tags
lymphoma
Stem Cells
cancer treatment
From
PRUnderground
Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma
December 14, 2021
Tickers
FATE
Tags
Briefs
Movers
lymphoma
From
Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
December 14, 2021
Tickers
GILD
Tags
Health Care
News
Market News
From
Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
December 13, 2021
Tickers
VIRX
Tags
News
Phase 1 Trial
Health Care
From
Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
December 13, 2021
Tickers
JAZZ
Tags
Market News
ASH21
Health Care
From
Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Phase 1 Trial
Health Care
News
From
Benzinga
Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients
December 13, 2021
Tickers
GILD
Tags
General
Benzinga
Phase 3 Trial
From
Benzinga
Bristol Myers Reveals Full Data For Breyanzi In Second-Line Lymphoma Setting
December 13, 2021
Tickers
BMY
Tags
Market News
General
BMY
From
Benzinga
TG Therapeutics Shares Plunge After FDA Plans AdComm Meet For Blood Cancer Candidate
November 30, 2021
Tickers
TGTX
Tags
Chronic Lymphocytic Leukemia
Benzinga
Movers
From
Benzinga
Affimed's Lymphoma Candidate Shows 100% Objective Response Rate At Highest Dose
November 22, 2021
Tickers
AFMD
Tags
Phase 2 Trial
General
Small Cap
From
Benzinga
Soligenix To File US Application For Its Lymphoma Photodynamic Therapy In 2H 2022
November 01, 2021
Tickers
SNGX
Tags
Briefs
Benzinga
lymphoma
From
Benzinga
IDI Consulting Supports the Leukemia & Lymphoma Society's Light The Night Walk
October 25, 2021
Tags
Pittsburgh
Event
Leukemia Lymphoma Society
From
PRLog
Gilead's Kite Files US Application To Expand Use Of Yescarta In Second-Line Setting
October 01, 2021
Tickers
GILD
Tags
GILD
Market News
General
From
Benzinga
BeiGene's Brukinsa Scores FDA Approval For Marginal Zone Lymphoma
September 15, 2021
Tickers
BGNE
Tags
Market News
BGNE
News
From
Benzinga
Soligenix Stock Moves Higher On US Orphan Drug Tag For T-cell Lymphoma Candidate
September 09, 2021
Tickers
SNGX
Tags
News
SNGX
Trading Ideas
From
Benzinga
ADC Therapeutics Announces $325M Financing Agreement With HealthCare Royalty
August 26, 2021
Tickers
ADCT
Tags
Briefs
oncology
lymphoma
From
Benzinga
Fate Therapeutics' Stem Cell-Derived NK Lymphoma Candidate Casts Doubt Over Durability Of Response
August 20, 2021
Tickers
FATE
Tags
FATE
General
lymphoma
From
Benzinga
Cellectar Receives $2M NIH Grant For Rare Lymphoma Study
August 18, 2021
Tickers
CLRB
Tags
Market News
Penny Stocks
Health Care
From
Benzinga
F-star's FS118 Development Program To Include Checkpoint Naïve Cancer Patients
August 12, 2021
Tickers
FSTX
Tags
Market News
News
FSTX
From
Benzinga
BeiGene's Brukinsa Scores Second Approval In Canada, This Time For Mantle Cell Lymphoma
July 26, 2021
Tickers
BGNE
Tags
General
Health Canada
FDA
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.